Does early postoperative erythromycin breath test correlate with hepatic cytochrome P4503A activity in liver transplant recipients?
Our data support the erythromycin breath test as a specific in vivo assay of CYP3A activity in humans. The test is applicable in liver transplant recipients in the early postoperative phase. Future studies should evaluate the clinical usefulness of an early postoperative erythromycin breath test as a predictor of cyclosporine-tacrolimus pharmacokinetics in liver transplantation.
H-UA induced global glomerular sclerosis and accelerated the progression of IgAN in CKD stage G3a.